Table 1.
Total (N = 30) |
35600 SU (N = 14) |
Placebo (N = 16) |
|
---|---|---|---|
n (%) | n (%) | n (%) | |
Gender [n (%)] | |||
Female | 16 (53.3%) | 7 (50.0%) | 9 (56.3%) |
Male | 14 (46.7%) | 7 (50.0%) | 7 (43.8%) |
Age [y] | |||
Mean (SD) | 32.1 (9.56) | 37.1 (9.37) | 27.8 (7.52) |
Median | 28.5 | 35.5 | 26.0 |
Range | 18–49 | 23–49 | 18–46 |
Race [n(%)] | |||
Black or African American | 3 (10.0%) | 1 (7.1%) | 2 (12.5%) |
White | 27 (90.0%) | 13 (92.9%) | 14 (87.5%) |
Ethnicity [n(%)] | |||
Hispanic or Latino | 8 (26.7%) | 2 (14.3%) | 6 (37.5%) |
Not Hispanic or Latino | 22 (73.3%) | 12 (85.7%) | 10 (62.5%) |
Body mass index at screening [kg/m2] | |||
Mean (SD) | 29.22 (6.82) | 30.44 (6.93) | 28.15 (6.75) |
Median | 28.62 | 29.01 | 26.69 |
Range | 15.8–47.4 | 22.7–47.4 | 15.8–40.3 |
Duration of grass pollen allergy [years] | |||
Mean (SD) | 14.90 (10.41) | 19.74 (12.85) | 10.67 (5.05) |
Median | 11.60 | 20.25 | 8.60 |
Range | 2.6–41.8 | 2.6–41.8 | 3.8–23.9 |